Form 4: Innoviva Director Receives Stock Options and RSUs

Innoviva, Inc. reports the grant of restricted stock units and stock options to Director Josephine Linden upon her board appointment.

Summary

• Josephine Linden, a Director at Innoviva, Inc., was granted restricted stock units (RSUs) and non-statutory stock options on May 18, 2026.
• The grants were made upon her appointment to the Board of Directors.
• The RSUs vest in equal installments on the first two anniversaries of the effective date.
• Additional options and RSUs will vest at the earlier of the next annual stockholder meeting or the one-year anniversary of the effective date, contingent on continuous service.
• Vesting acceleration is possible upon death, disability, or a change in control, provided certain conditions are met.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports routine equity grants to a director upon appointment, which is standard corporate practice and does not inherently signal significant positive or negative developments for the company's financial performance.

Positives

• Director Josephine Linden has been granted equity awards (RSUs and stock options) as part of her board appointment, aligning her interests with shareholders.
• The equity awards include provisions for vesting acceleration in certain beneficial events like death, disability, or change in control.

Risks

• The vesting of additional RSUs and options is contingent on the Reporting Person's continuous service as an Outside Director through the applicable vesting date.
• Vesting acceleration upon a change in control is subject to the condition that the Reporting Person has not experienced a termination prior to such event.

Future Outlook

The filing does not contain specific forward-looking financial guidance. It details the vesting schedule and conditions for equity awards granted to a director.

Industry Context

StockSavvy.ai notes that the grant of equity awards to new directors is a common practice in the biotechnology and pharmaceutical sectors, including companies like Innoviva, Inc., to attract and retain experienced leadership and align executive incentives with long-term shareholder value.

Management Changes

Stakeholder Impact

• Shareholders: The grant of equity awards to directors aligns their interests with shareholders, potentially fostering a focus on long-term value creation.
• Employees: While not directly impacted, standard director compensation practices can influence overall company compensation philosophy.
• Management: The filing details compensation for a board member, which is a standard aspect of corporate governance.

Next Steps

• Vesting of RSUs on the first two anniversaries of May 18, 2026.
• Vesting of additional RSUs and options at the sooner of the next annual stockholder meeting or the one-year anniversary of May 18, 2026, subject to continuous service.
• Potential accelerated vesting upon death, disability, or change in control.

Key Dates

Keywords

Innoviva Inc, INVA, Form 4, Director Compensation, Stock Options, Restricted Stock Units, Equity Awards, Beneficial Ownership, SEC Filing